Mounjaro vs Ozempic for Women Over 40: Which Works Better?

If you're a woman over 40 struggling with weight loss despite doing everything right, you're not alone. Hormonal changes, slower metabolism, and life stress make weight management genuinely harder in your 40s and beyond. That's why so many women are asking their doctors about GLP-1 medications like Mounjaro and Ozempic.

But which one is better for your body at this stage of life? Let's break down what makes these medications different and what you should consider when talking to your doctor.

Understanding the Basics: What Are These Medications?

Both Mounjaro and Ozempic belong to a class of medications that help regulate blood sugar and support weight loss, but they work slightly differently.

Ozempic contains semaglutide, a GLP-1 receptor agonist. It mimics a hormone your body naturally produces that tells your brain you're full and helps regulate blood sugar levels.

Mounjaro contains tirzepatide, which is a dual-action medication. It activates both GLP-1 receptors and GIP receptors, which may explain why some people see more significant results.

Both were originally developed for type 2 diabetes but have shown remarkable benefits for weight management, which is why they've become so popular among women navigating the metabolic challenges of perimenopause and menopause.

How They Compare for Women Over 40

Weight Loss Results

Clinical trials show that Mounjaro typically produces slightly more weight loss than Ozempic. In studies, people taking the highest dose of Mounjaro lost an average of 15-20% of their body weight, while those on Ozempic lost around 10-15%.

For women over 40, this difference matters because hormonal changes often make weight loss more stubborn. The additional GIP receptor activation in Mounjaro may offer an extra boost when your metabolism is working against you.

That said, individual results vary widely. Some women respond beautifully to Ozempic and experience minimal side effects, making it the better choice despite potentially less dramatic weight loss.

Impact on Metabolism and Hormones

Women over 40 face unique metabolic challenges. Declining estrogen affects how your body stores fat, processes insulin, and regulates appetite. Both medications help address insulin resistance, which typically worsens during perimenopause.

Mounjaro's dual action may provide additional metabolic benefits for women dealing with significant insulin resistance. However, Ozempic has been studied longer and has more real-world data about how it interacts with hormonal changes in midlife women.

Neither medication directly replaces or affects your hormone levels, but by improving insulin sensitivity and reducing inflammation, both can make your body more responsive to the hormones you do have.

Side Effects to Consider

Both medications can cause similar side effects, primarily digestive issues like nausea, constipation, or diarrhea. These typically improve after the first few weeks as your body adjusts.

Some women report that Mounjaro causes slightly more nausea initially, possibly because of its dual mechanism. However, this isn't universal, and many women tolerate it beautifully.

For women over 40, it's worth noting that these medications can affect how you absorb other medications, including thyroid medication or hormone replacement therapy. Always discuss your complete medication list with your doctor.

Dosing and Convenience

Both medications are once-weekly injections, making them convenient compared to daily medications. Ozempic comes in pre-filled pens with doses of 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Mounjaro offers doses ranging from 2.5 mg up to 15 mg.

Your doctor will start you on a low dose and gradually increase it to minimize side effects. This titration process typically takes several months with either medication.

Special Considerations for Women Over 40

If you're experiencing perimenopause or menopause symptoms, these medications won't directly address hot flashes or mood swings. However, losing excess weight can reduce the severity of some menopausal symptoms.

Women over 40 are also more likely to have other health conditions like high blood pressure, high cholesterol, or prediabetes. Both Mounjaro and Ozempic can improve these conditions alongside weight loss, but your complete health picture should guide which medication is right for you.

Bone health is another consideration. Rapid weight loss at any age can affect bone density, which is already a concern for women after menopause. Make sure you're getting adequate calcium, vitamin D, and resistance exercise while on these medications.

Cost and Accessibility

Brand-name Mounjaro and Ozempic can be expensive without insurance coverage, often exceeding $1,000 per month. Insurance coverage varies widely and often requires prior authorization and documentation of medical necessity.

Compounded versions of these medications offer a more affordable option for many people. These pharmacy-prepared alternatives contain the same active ingredients at a fraction of the cost.

Which One Should You Choose?

There's no universal right answer. The best medication depends on your individual health history, how your body responds, what side effects you can tolerate, and what you can afford.

Mounjaro might be the better choice if you have significant insulin resistance, haven't had success with other weight loss medications, or have a higher amount of weight to lose. Ozempic might be preferable if you want a medication with a longer track record, are sensitive to medications, or are already seeing good results.

The most important factor is working with a doctor who understands your complete health picture and the unique challenges women face after 40. These medications work best as part of a comprehensive approach that includes nutrition, movement, stress management, and addressing any hormonal imbalances.

From the Ozari Care Team

Many women over 40 see excellent results with either medication, but patience is key. It typically takes 8-12 weeks to see significant changes, and the best results come when you view these medications as tools that support sustainable lifestyle changes rather than quick fixes. We also recommend discussing whether you're a candidate for hormone replacement therapy alongside GLP-1 treatment, as addressing estrogen deficiency can enhance your overall metabolic health.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026